The American Journal of Medicine
Volume 119, Issue 10, Supplement 1 , Pages 1-3 , October 2006

Introduction

  • Donald P. Tashkin, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Donald P. Tashkin, MD, Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, University of California–Los Angeles, 10833 Le Conte Avenue, Los Angeles, California 90095-1690

References 

  1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease—Updated July 2004 . Bethesda, MD: US Dept of Health and Human Services, National Institutes of Health; 2005;
  2. Jones PW , Bosh TK . Quality of life changes in COPD patients treated with salmeterol . Am J Respir Crit Care Med . 1997;155:1283–1289
  3. Rabe K . Outcome measures in COPD . Prim Care Respir J . 2004;13:177–178
  4. Cooper CB . Exercise in chronic pulmonary disease: limitations and rehabilitation . Med Sci Sports Exerc . 2001;33(suppl):S643–S646
  5. Celli BR , MacNee W . Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper . Eur Respir J . 2004;23:932–946
  6. Pauwels RA , Buist AS , Calverley PM , Jenkins CR , Hurd SS . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary . Am J Respir Crit Care Med . 2001;163:1256–1276

PII: S0002-9343(06)00922-3

doi: 10.1016/j.amjmed.2006.08.001

The American Journal of Medicine
Volume 119, Issue 10, Supplement 1 , Pages 1-3 , October 2006

Article Tools